AMRI to Present at Barclays Global Healthcare Conference
Get Alerts AMRI Hot Sheet
Join SI Premium – FREE
ALBANY, N.Y., March 3, 2017 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer, will present at the Barclays Global Healthcare Conference on Thursday, March 16, 2017 at 10:45 a.m. ET. A live audio webcast of the presentation can be accessed at AMRI's Investor Relations website at http://ir.amriglobal.com/events.cfm?CalendarID=2
The webcast will be archived for 90 days following the live presentation.
About AMRIAlbany Molecular Research Inc. (AMRI) is a global contract research and manufacturing organization that has been working with the Life Sciences industry to improve patient outcomes and the quality of life for more than two decades. With locations in North America, Europe and Asia, our key business segments include Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API), Drug Product (DP), and Fine Chemicals. For more information about AMRI, please visit our website at www.amriglobal.com or follow us on Twitter (@amriglobal).
Contacts
Investors Patty EisenhaurAMRI Investor Relations518.512.2936[email protected]
MediaGina RotheAMRI Communications518-512-2512[email protected]
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/amri-to-present-at-barclays-global-healthcare-conference-300417019.html
SOURCE AMRI
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Devon Announces Expiration and Final Results of its Private Exchange Offers and Consent Solicitations
- Canada Nickel Awards Exclusive Mandate for US$600 million Investment Tax Credit Loan Facility to SB1 Markets AS
- German Crews Join Italy’s round‑the‑coast Marina Militare Nastro Rosa Tour 2026
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Barclays, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share